INNOVATE TO ELEVATE VIETNAM’S HEALTHCARE INDUSTRY

The “Healthcare Innovation Forum”, a platform that brings together local and international experts to discuss and share experiences on innovative solutions in building a sustainable healthcare system worldwide and to drive the adoption of innovative approaches and technologies to transform healthcare in Vietnam.

Diseases never stop developing, nor does innovation to deal with these obstacles. The global life sciences sector has emerged as one of the key drivers of the 21st-century economy, driven by remarkable breakthroughs in healthcare, alongside an increasing social demand to address healthcare challenges.
Aiming to inspire a transformative approach to level up Vietnam’s healthcare, the second Healthcare Innovation Forum, initiated by Pharma Group, was organized on October 18, 2023, in Hanoi and virtually via Zoom.

In the momentum of the 2022 event’s success, this year’s forum will centre its discussions around three key factors aimed at expediting the realization of Vietnam’s healthcare development vision. It includes: (i) Enhancing research and clinical trial capabilities; (ii) Fostering innovation in healthcare infrastructure construction, from the digitalization of the healthcare system, the adoption of advanced technological solutions like artificial intelligence (AI) and real-world data management to drive innovative practices and establish a resilient healthcare system, to the elevation of Vietnam’s competitive position in the field of pharmaceutical Good Manufacturing Practice (GMP) within the region; (iii) Creating a policy environment that encourages groundbreaking advancements in the industry’s growth.

The 2023 Forum is honoured to receive Dr. Mary Harney, Former Deputy Prime Minister/Tanaiste (1997 – 2006), Minister of Health and Children (2004 – 2011) – Republic of Ireland. In 2020, Ireland became the world’s largest exporter of medicines, with 19 out of the top 20 global pharmaceutical companies establishing their presence in the country. Dr. Mary Harney’s term coincides with the decade (1997 – 2007) of Ireland’s booming economic growth and what has come to be known as the Celtic tiger area with an annual GDP growth rate of over 9.4% and the country’s transformation from one of the lowest starting points in Europe to one of the most powerful exporters of pharmaceutical products in the world with a value of 71 billion USD/year. Dr. Mary Harney’s sharing of practical experiences is sure to offer valuable and useful reference information for the development of policies and strategies in Vietnam.

Vietnam’s total health spending per capita has increased by an average of 11% annually over the past decade, according to the Ministry of Health. The average number of hospital visits per person in Vietnam has risen from 1.89 visits per year in 2010 to 2.95 visits per year in 2020. Vietnam has the second highest total expenditure on health care in terms of percentage of GDP in the Southeast Asian region, only after Cambodia.

The increasing demand for healthcare shows the role and importance of innovation in the healthcare sector to improve the quality of healthcare, enhance diagnostic and treatment capabilities, as well as promote progress in medical research, thereby ensuring sustainable development in the healthcare field. Accessing and promoting innovation and development in healthcare is a key factor in the process of restructuring and improving Vietnam’s healthcare system to better respond to future challenges.
Digital transformation in healthcare has been among the key focal points of the Vietnamese government, in line with the global trend. Recently, the Ministry of Health promulgated the Health Digital Transformation Programme with a vision towards 2030. Some of the proposed goals include ensuring security in medical data management, disease management and public health on digital platforms as well as applying digital technologies such as Artificial Intelligence (AI), Big Data, Internet of Medical Things (IoMT), and Blockchain, in healthcare activities. In collaboration with top healthcare experts in Vietnam, the content presented and discussed by international experts in the field of digital technology from IQVIA and Microsoft are expected to offer intriguing insights and valuable experiences for digital transformation efforts in Vietnam.

The event this year also marks the anniversary of 25 years of partnership between the health sector in Vietnam with Pharma Group and its members, with the same sustainable goal for a healthy and prosperous Vietnam from an innovation-based foundation.

The forum is expected to attract a wide range of attendees, including Representatives of the Government of Vietnam, Embassies, the medical community (Medical Associations, Healthcare Practitioners, Hospital representatives), world-leading universities and research institutes, Medical-Pharma Universities in Vietnam, International experts, healthcare and pharmaceutical companies both domestically and internationally, and Media.

Source: Vietnamnews

About STELLAPHARM

Stellapharm is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, antiviral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.

The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.

Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An City, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: info@stellapharm.com | W: www.stellapharm.com

You May like

19 Dec 2023

SHORTEN LICENSING PROCEDURES, ENCOURAGE INVESTMENT, AND TRANSFER PHARMACEUTICAL TECHNOLOGY

  The Circular is an important legal basis for attracting investment activities and transferring technology for drug production, especially original brand name drugs, patented drugs, specialized drugs, special treatments, and prescription drugs. generic drugs in the form of high-tech dosage forms, vaccines, reference biological products, and similar biological products according to the orientations in the

14 Dec 2023

VIETNAM AIMING TO BECOME REGIONAL PHARMACEUTICAL PRODUCTION CENTER

Vietnam has set a target of becoming a high-value pharmaceutical production center in the region under its strategy for the development of the pharmaceutical sector by 2030 with a vision to 2045. Under the strategy, which was approved by Deputy Prime Minister Tran Hong Ha on October 9, Vietnam will strive to develop its pharmaceutical

09 Dec 2023

PHARMACEUTICAL INDUSTRY STRIVES TO PRODUCE NEW DRUG FORMS

Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use. Vietnam is focusing on improving research capacity and application of new drug production technology, promoting clinical pharmacy development and strengthening supervision of safe and reasonable drug use, aiming

18 Dec 2023

BIG PHARMA BETS ON AI TO SPEED UP CLINICAL TRIALS

Major drugmakers are using artificial intelligence to find patients for clinical trials quickly, or to reduce the number of people needed to test medicines, both accelerating drug development and potentially saving millions of dollars.Human studies are the most expensive and time-consuming part of drug development as it can take years to recruit patients and trial

04 Dec 2023

TOP 10 REPUTABLE PHARMACEUTICAL COMPANIES IN 2023

On November 28, 2023, Vietnam Evaluation Report Joint Stock Company (Vietnam Report) officially announced the Top 10 prestigious Pharmaceutical Companies in 2023. Top 10 reputable Pharmaceutical Companies are built on scientific and objective principles. Companies are evaluated and ranked based on 3 main criteria: (1) Financial capacity shown on the most recent year’s financial statements;

03 Dec 2023

A FOCUS ON THE IMPROVEMENT OF PEOPLE’S LIVES BY PROVIDING EFFECTIVE AND AFFORDABLE TREATMENTS.

By Mr. Ong Van Dung, General Director, Stellapharm   Stellapharm (former name was STADA-VN – a Joint Venture Pharmaceutical Company formed in 2002 with a Vietnamesecompany named M.S.T and German cooperation named STADA Arzneimittel). Stellapharm has become one of the leading generic pharmaceutical manufacturers in Vietnam, we follow the global quality standard in accordance with